BioStratum Challenges Affidavit Asserting Pre-1994 Pyridoxamine Product
Hopeful pyridoxamine drug marketer BioStratum is skeptical of an affidavit submitted to FDA by Jarrow Formulas as evidence of the pre-1994 sale of pyridoxamine in supplements
Hopeful pyridoxamine drug marketer BioStratum is skeptical of an affidavit submitted to FDA by Jarrow Formulas as evidence of the pre-1994 sale of pyridoxamine in supplements